BLT 0.00% 2.6¢ benitec biopharma limited

Why not pursue a merger with Calimmune and develop their new...

  1. J8
    14,558 Posts.
    lightbulb Created with Sketch. 826
    Why not pursue a merger with Calimmune and develop their new vectors and go for more conditions. Trials can be here and the US. We are paying 4D a lot of money to get the AMD vector right but Calimmune are also developing vectors.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.